NEW ORLEANS, LA—Treating patients with symptomatic rheumatic heart disease (RHD) with digoxin appears to modestly reduce the risk of all-cause mortality or new-onset or worsening heart failure (HF), ...

In patients with heart failure with reduced ejection fraction (HFrEF) who have an implantable cardioverter-defibrillator (ICD), the use of digoxin may increase the risk of ventricular tachyarrhythmia ...

A randomized trial shows no significant difference in the primary endpoint of quality of life at 6 months between treatment with digoxin vs the beta-blocker bisoprolol (Zebeta) in patients with atrial ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience new-onset or worsening heart failure during a two-year follow-up compared with ...

Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...

Millions of Americans take a daily handful of supplements alongside prescription heart or thyroid drugs, often without ...

A major clinical trial, led by researchers from All India Institute of Medical Sciences (AIIMS), has found that the low-cost heart drug digoxin may help reduce worsening heart failure in patients ...

We wish to report our experience with 72 patients who were treated with acetyldigitoxin. § Forty-nine were given a full digitalizing dose and maintained thereafter on acetyldigitoxin, whereas 23 ...